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ABSTRACT:  
The repair of large long bone defects requires complex surgical procedures as the bone loss cannot 
simply be replaced by autologous grafts due to an insufficient bone stock of the human body. Tissue 
engineering strategies and the use of Advanced Therapy Medicinal Products (ATMPs) for these 
reconstructions remain a considerable challenge, in particular since robust outcomes in well-defined 
large animal models are lacking. To be suitable as a model for treatment of human sized bone defects 
we developed a large animal model in both skeletally immature and mature sheep and made close 
observations on the spontaneous healing of defects. We warn for the spontaneous repair of large 
defects in immature animals which can mask the (in)effectiveness of ATMP therapies and propose the 
use of large 4.5 centimeter defects that are pretreated with a PMMA spacer in skeletally mature 
animals. 
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INTRODUCTION 
The reconstruction of large skeletal defects in long bones remains a challenge in orthopaedic surgery.1 
Free or vascularized autologous grafts, bone transport techniques and allografting are potential 
treatments, all with their advantages but also drawbacks.2,3 They require long term therapeutic 
management and put patients prone to substantial morbidity.4 Improved strategies in tissue 
engineering might overcome some of the burning problems in bone repair. Most researchers agree on 
the principle that an adequate reconstruction needs an appropriate carrier, growth factors, 
osteoprogenitor cells and a favorable mechanical environment, also known as the ‘diamond 
concept’.5,6 Moreover, a good quality of the surrounding tissues allows better bone regeneration, but 
is not always possible, in particular in large defects or infected non-unions with substantial damage of 
the periosteum. To overcome the challenge of the compromised environment, Masquelet initiated the 
concept of an induced membrane by a foreign body reaction, for which he used 
polymethylmethacrylate bone cement (PMMA).7,8 This allows the creation of a so-called biochamber 
in which a bone graft or an Advanced Therapy Medicinal Product (ATMP), can be implanted.9 In 
combination with the diamond concept this adds a fifth element to the prerequisites for an ideal bone 
healing, and has been described as the Pentaconcept.10 
The main challenge in evaluating new ATMPs is the use of a suitable model that ideally mimics the real 
clinical situation, and predicts the outcome in the patient. Therefore critical sized bone defects in large 
animals are mostly used. A variety of defect models has been described and usually tested as ‘active 
implanted’ versus ‘empty control’ defects. However there is not always a consensus in literature about 
the exact definition, nor the ideal way to create large skeletal defects. But nevertheless good models 
for preclinical testing are an absolute prerequisite to bring therapies to the patient.11,12 In the field of 
bone repair, and this in contrast to other domains of tissue engineering where the biological 
phenomena are dominant, the geometric and mechanical conditions also play an indisputable role 
which need to be taken into account in the translational research.13,14 
To obtain a reliable model of a defect pseudarthrosis we set up an experiment in both skeletal 
immature and mature sheep, creating tibial bone defects of both 3.0 and 4.5 cm in immature and 4.5 
cm in mature animals, according to the guidelines that critical size defects should be at least 2 to 2.5 
times the diameter of the bone15 These gaps were left empty during a period of 6 weeks to allow 
ingrowth of fibrotic scar tissue that was subsequently removed for the implantation of a cement spacer 
for another 6 weeks to induce a Masquelet membrane. The way these defects were created, is 
described in detail emphasizing that critical size defects have to be interpreted with extreme caution 
as it is not uncommon that in empty defects, prior to cement insertion, spontaneous repair occurs. 
 
MATERIAL AND METHODS 
All experiments were performed with approval of the Ethical Committee of the Medanex Clinic (CRO, 
Diest, Belgium) and in accordance with the guidelines for the care of laboratory animals. Forty 
Charolais-Swifter sheep were used and divided into 32 skeletal immature (10 months old) and 8 mature 
(4 years old) sheep (Table 1). After sedation by xylazin (0.1mg/kg; Xyl-M 2%®, VMD, Arendonk, 
Belgium) intravenously anesthesia was installed by ketamine (4 mg/kg Ketamine 1000®, Ceva Santé 
Animale, Libourne, France) and midazolam (0.2 mg /kg; Dormicum®, Productos Roche S.A. de C.V., 
Toluca, Mexico), using a jugularis catheter that could serve for postoperative intravenous 
administration of medication. For antibiotic prophylaxis the second generation cephalosporin ceftiofur 
(2.2 mg/kg; Excenel®, Phizer Animal Health, Kirkland, Canada) and Natriumbenzylpenicilline 40000 
IU/kg; Penicillin®, Kela NV, Hoogstraten, Belgium) were administered. Endotracheal intubation was 
performed and the anesthesia was maintained with isoflurane, using buprenorphine (0.005 mg/kg; 
Vetergesic®, Pantheon UK Limited, Wiltshire, United Kingdom) and meloxicam (0.5 mg/kg Metacam®, 
Boehringer Ingelheim Vetmedica GmbH, Ingelheim, Germany) for painkilling. The sheep were installed 
in lateral decubitus on the left side giving a free exposure to the right hind limb that was carefully 
clipped, scrubbed and draped. An Ilizarov fixator (Medicalplastic, Milano, Italy) was installed to the 
right tibia (Fig. 1). Proximally, one and a half ring were fixed to the bone with three 1.8 mm Kirschner 
wires (Smith & Nephew, Memphis, Tennessee, USA) and three (one lateral, two medial) 4 millimeter 
selftapping Apex screws (Stryker, Selzach, Switzerland), both for 3.0 and 4.5 cm defects. Distally two 
1.8 mm wires and 2 medial 4 millimeter Apex screws were anchoring the bone to one ring that was 
temporally interconnected with the proximal ring with two threated rods for the 3 cm defects. For 
defects of 4.5 cm an additional distal half ring with one 1.8 mm Kirschner wire and one 4 mm Apex 
screw was used. The wires were tensioned to 130 kilogram, using the dynamometric Ilizarov spanner 
(Fig. 1). Subsequently a medial incision was made at mid-diaphyseal level and a tibial segment of 3 cm 
was outlined in 12 young, skeletal immature sheep, and of 4.5 cm in 20 young and the 8 adult sheep. 
At this stage the periosteum was excised as far as the exposure allowed. At the proximal and distal 
level 3.2 mm drill holes were made. An osteotomy was performed with a chisel at both ends and the 
fragment removed (Fig. 2a). Finally the remnants of the periosteum blended to the fascia covering the 
muscles at the lateral side of the tibia were removed meticulously by excising the entire fascia.   
In all animals (n = 40) the wounds were simply closed leaving the cavity empty. The rings were firmly 
interconnected with four threated rods and all parts of the fixator were carefully controlled to avoid 
any mechanical instability. Finally the alignment of the bone fragments was checked under image 
intensifier and the images collected.  
After the operation all animals were allowed to move freely and bear full weight on the operated limb. 
Antibiotics were continued intravenously for five days. Meloxicam, the non-steroidal anti-
inflammatory drug (NSAID) already started during the surgical procedure, was continued for 5 days at 
a dose of 0.5mg/kg. 
Radiographic assessment in an anteroposterior and lateral direction was performed immediately 
postoperatively and at six weeks, just before re-intervention and assessed according the presence of 
bone in the defect. The amount of bone was expressed as a percentage of the surface of the defect in 
both planes. At this stage in all sheep, in as far as the cavity was not closed spontaneously, on which 
occasion no further surgery was undertaken, the defect sites were debrided from scar tissue and filled 
with a cement spacer (Fig. 2b-c). For this Masquelet procedure a PMMA spacer was prepared 
(Palacos®, Heraeus Medical, Wehrheim, Germany) and just before hardening inserted in the bone 
defect thereby slightly draping the cement around the bony edges. During hardening of the PMMA in 
the defect site, the cement spacer was continuously cooled with a solution of NaCl 0.9% (B.Braun, 
Melsungen AG, Melsungen, Germany) to avoid thermal damage to the surrounding tissues. The 
cement was carefully covered by closing the subcutaneous tissue followed by skin sutures. These 
animals were followed for another 6 weeks and again radiographically evaluated at removal of the 
cement, on which occasion a biopsy of the membrane was taken (Fig. 2d–e). Subsequently all animals 
were treated with an ATMP implantation as part of a larger ongoing experiment which is beyond the 
scope of this publication (Fig 3). 
Statistical analysis was performed using the two-tailed Fischer’s exact test with the significance level 
set at p< 0.05 (GraphPad Software, Inc. La Jolla, CA USA).    
 
     
RESULTS 
All sheep recovered well and were able to bear weight on the operated hind limb. Apart from some 
superficial pin tract infections that could be treated with intravenous antibiotics or local disinfection, 
there were no complications. Alignment of the limb was maintained on all occasions and there were 
no problems with the fixator hardware. The radiographic assessment at day one showed a complete 
empty cavity in the 40 sheep  (32 young, 8 adult). 
In the 12 young animals with a 3 cm empty defect a substantial bone repair was noticed in 6 of them 
with more than 50% filling after 6 weeks (Fig. 4). These 6 animals were not further operated and 
followed for another 2 years with radiographic assessment at 3 monthly intervals, showing a complete 
filling of the defect. The other 6 animals stayed free of any significant bone formation and at re-
intervention a fibrotic block of scar tissue was excised to allow the insertion of a cement spacer. From 
the 20 young sheep with a 4.5 cm defect, new bone formation at the posterolateral position of the 
defect was noticed in 5 animals filling less than 50% of the defect surface whereas 15 had no signs or 
only a very limited amount of bone repair. In all 20 sheep the scar tissue and the occasional bone 
ingrowth were removed at six weeks prior to cement implantation (Fig. 5 a).  
In the 8 adult sheep with the 4.5 cm defect no bone formation at all or a limited bone outgrowth at 
the bone edges could be noticed, and at re-intervention the cavities were completely filled with a block 
of fibrotic scar tissue that was excised for the insertion of the spacer (Fig. 5 b) (Table 1). 
All cement spacers were removed after another six weeks and at this stage the animals were used for 
further experiments aiming at defect reconstruction with ATMPs which results are subject of further 
analysis and do not contribute to the present report.  
The Masquelet membrane formation was adequate in all animals, regardless the defect size and at 
histological analysis a fibrovascular membrane was found on each occasion. The radiographic analysis 
at removal of the spacer did not show any relevant bone formation around the spacer. The difference 
in outcome for mature versus immature animals with a 4.5 cm defect was not significant at the p < 
0.05 level (p-value: 0.2808); the comparison between a 3 cm and 4.5 cm defect in skeletal immature 
animals was found to be not significant (p-value: 0.2499). The results in immature 3 cm defects 
compared to mature 4.5 cm defects showed a significant difference (p-value: 0.0419). 
 
DISCUSSION 
One of the biggest challenges in defect reconstruction research is the translation of experimental data 
to the clinic. Because surgeons are usually confronted with very large defects, models have to be 
developed that are relevant for the patients that are in need of treatment. If complex reconstruction 
procedures become necessary,  advanced therapy medicinal products (ATMPs) can bring a solution, 
but to study their value in clinically relevant conditions, representative large animal defects, mimicking 
the clinical situation as recommended in the European Medical Agency (EMA) guidelines, should be 
used.16 FDA directories suggest that the chosen models should relate to the overall product 
development and that the clinical product should be tested in the preclinical animal model in its final 
formulation rather than an equivalent one, for which in this particular case ‘human size-like’ defects 
are desirable.17 
For the use of large so called critical size defects in animals of appropriate size such as goats and sheep 
uttermost care should be taken.12,18  Apart from the size, suggested to be 2 to 2.5 times the diameter 
of the bone, other parameters have to be taken into account such as the age  of the animal (skeletal 
immature versus adult) and the way the defect is created, e.g. by careful removal or not of the 
periosteum.19 Also the fact whether a defect reconstruction is studied immediately after its creation 
(the optimal fresh defect) or after some delay allowing ingrowth of fibrosis and mimicking the real 
clinical situation of a defect non-union, might alter the outcome. The anatomic localization that is 
chosen should also be equal to the clinical situation as in practice most defect non-unions are localized 
in the long weight bearing bones, especially the tibia. Also the time to follow-up should not be 
underestimated as early bone formation might not be entirely clinically relevant and early promising 
results might finally turn out not to be successful. On the other hand slow onset regeneration can 
progressively evolve and lead to a well maturated callus. Moreover there is the phenomenon of 
spontaneous bone regeneration which can occur in a model and thus interfere with the implant that 
is examined and this ‘background noise’ can lead to over- enthusiastic conclusions about the netto 
effect of ATMPs. It can to some extent be responsible for the alleged new bone formation of 
experimental treatments and in case such models would be used for direct ATMP insertion, the 
evaluation of the newly formed bone could be falsely positive and lead to exaggerated optimistic 
conclusions.20 Neglecting the rules of good preclinical testing could create unrealistic expectations, and 
is probably the reason why so many bright ideas and novel developments in tissue engineering never 
come from bench to bedside as the translational research is poorly or incorrectly performed. 
Finally the fixation method can also interfere with the bone restoration, and this as well in a negative 
way due to an insufficient stability or even positively due to collapse and compression forces on one 
side promoting the healing due to the partially reduced defect size.  
Reichert et al made a substantial contribution to the study of large animal defects and concluded that 
many reports in the literature have serious shortcomings making them unreliable as a model for 
translational studies. The authors pointed out that the ideal defect is a midshaft tibial gap of minimum 
three cm in adult sheep for which they recommend an age between 7 and 9 years as the morphologic 
characteristics of the bone mimic the adult human situation best at this age.21  
A critical analysis of our results also shows that defect length is important but should be correlated 
with the age of the animal. Taking a length of 2 to 2.5 times the diameter, which is considered as a 
standard according to site of American Standards for Testing and Materials ASTM, and leading to a 
segmental bone deficit of 3.0 cm in immature animals, respectively 4.5 cm in skeletally mature ones 
has a different outcome if left untreated.15 Whereas none of the eight adult sheep had any relevant 
bone repair and thus a real critical size defect, half of the young animals with a 3 cm defect showed a 
healing tendency with finally a complete bridging. Even a 4.5 cm defect in young animals gives a partial 
regeneration in one quarter of the animals as illustrated in figure 4a. Despite careful removal of the 
periosteum the biological potential of young animals is overwhelming leading to a spontaneous repair 
even in a compromised environment, i.e. biologically deprived from osteoprogenitor cells and with 
critical dimensions. As the circular fixator maintains the reduction throughout the experiments without 
any collapse or loss of reduction, this good mechanical stability allows an optimal function of the 
biological processes with unforeseen regenerative capacities as demonstrated in 11 of the 36 skeletal 
immature animals, although they strictly fulfilled the requirements of critical size defects. Even 
statistical analysis should be interpreted carefully. There is no significant difference between the 
mature versus immature animals, nevertheless in some of the immature is a partial bone regeneration 
present. In case only more limited groups are used, statistical differences could become significant. 
Between 3 cm immature versus 4.5 cm mature sheep there is a significant difference from which we 
would recommend for the use of adult models. If an immature model would be used for the study of 
bone reconstruction by immediate insertion of an ATMP the results would be overshadowed by the 
spontaneous bone formation and lead to potentially false interpretations. On the other hand, the same 
conditions in an adult animal did prove to be reliable and can be considered as a real critical size defect.  
The insertion of cement after six weeks of fibrotic ingrowth, thereby mimicking the real clinical 
condition of a compromised environment compared to a membrane induction in a freshly created 
defect as done in most studies, is more reliable but needs further experiments on a potential difference 
in the biological activity of the membrane and the subsequent capacity for bone regeneration.22 
Finally, for an optimal study of bone reconstruction we suggest that the fixation technique should 
barely interfere with the gap were the biological repair processes should take place and we believe 
that external fixation is most reliable to study the behavior of the critical size defect. Moreover it allows 
a full interpretation of the newly formed bone in vivo using conventional radiological and even CAT-
scan imaging.23 To overcome the shortcomings of unilateral fixation, which sometimes does not allow 
to maintain a good reduction or full weight bearing, circular fixation is a perfect alternative as shown 
in our experiments. Indeed, mechanical stability and maintenance of alignment and defect size was 
never a problem and allowed free use of the limb and unrestricted walking of the animal mimicking 
the clinical situation. 
Taken together the presented data clearly suggest that any interpretation of bone formation in critical 
sized defects has to be done with regard to both the biological situation and mechanical environment 
and failure to do so, could create the impression of promising therapies that finally will not work in 
surgeons’ hands. 
CONCLUSION 
The translation of laboratory based approaches for bone defect repair to a relevant clinical situation 
will only succeed if correctly performed studies in a reliable large animal model demonstrate that the 
proposed strategy is successful. This approach will avoid failures and impede that patients become 
prone to unnecessary and avoidable morbidity.   
To create an absolute critical defect the authors recommend the use of the tibia of adult sheep, the 
creation of a defect of sufficient size (4.5cm) with careful resection of the entire periosteum, a latency 
period of 6 weeks to allow ingrowth of fibrosis followed by a cement spacer during 6 weeks. In order 
to avoid interference with the fixation we prefer an external circular fixator that allows a perfect 
stabilization with preservation of the reduction and full weight bearing without restrictions. Only if all 
these parameters are taken into account and strictly fulfilled we speak about a real critical size defect. 
This ideal defect/non-union model is not only suitable but even indispensable for clinical relevant 
translational investigations leading to reliable conclusions. 
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FIGURE LEGENDS 
Figure 1:  Right hind limb of sheep with circular external fixator to stabilize the tibial bone defect 
Figure 2: Outline of 4,5 cm tibial defect just before removal (a); defect fully filled with fibrosis (b); 
cement spacer after debridement (c); formation of the Masquelet membrane (*) after 6 weeks (d); 
critical size empty defect after cement removal (e) 
Figure 3: Schematic overview of the experimental design of the surgical intervention for a 3 cm and a 
4.5 cm defect in a sheep tibial defect model 
Figure 4: Empty 3 cm defect in skeletal immature animal at operation (a) and spontaneous 
regeneration at 6 weeks postoperatively (b) 
Figure 5: Comparison of 4,5 cm tibial defect in skeletal immature (a) and mature (b) sheep showing a 
partial spontaneous regeneration at the lateral side in the immature animal but neglectible bone 
formation in the mature one at 6 weeks postoperatively 
  
Table 1: Treatment groups and bone formation 
 
                
 
 
 
  
Treatment  Group    Bone formation     
 
 
Bone formation  
(30-80%) 
No bone or 
limited (<10%) 
Empty defect 3 cm  Skeletal immature 
n = 12 
6 6 
Empty defect 4.5 cm  Skeletal immature 
n= 20 
5 15 
Empty defect 4.5 cm Skeletal mature 
n= 8 
0 8 
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